產(chǎn)品基本信息
產(chǎn)品編號：N200705
產(chǎn)品名稱：(S)-(-)-Nadifloxacin
產(chǎn)品CAS：154357-42-3
規(guī)格含量：10mg
產(chǎn)品價(jià)格：面議
聯(lián)系我們:
產(chǎn)品詳細(xì)介紹
標(biāo)準(zhǔn)品編號:
N200705
名稱:
(S)-(-)-Nadifloxacin
別名:
(S)-9-Fluoro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-6,7-dihydro-1H,5H-pyrido[3,2,1-ij]quinoline-2-carboxylic Acid; (5S)-9-Fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-1H,5H-benzo[ij]quinolizine-2-carboxylic Acid; (S)-9-Fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-1H,5H-Benzo[ij]quinolizine-2-carboxylic Acid; Levonadifloxacin;
CAS號:
154357-42-3
分子式:
C??H??FN?O?
分子量:
360.38
種類:
Standards; Pharmaceutical/API Drug Impurities/Metabolites; Antibotics;
應(yīng)用:
(S)-(-)-Nadifloxacin is an anti-bacterial agent against multidrug-resistant Staphylococcus aureus. Also, it is derived from 6-Fluoro-2-methylquinoline (F595900), which is an quinoline derivative, a highly potent thrombin receptor antagonist.
參考文獻(xiàn)
Hashimoto, K., et al.: Chem. Pharm. Bull., 44, 642-645 (1996); De Souza, N. J., et al.: J. Med. Chem., 48, 5232-5242 (2005); Davie, E., et al.: Biochemistry, 30, 10363 (1991), Vu, T., et al.: Nature, 353, 674 (1991), Nanevicz, T., et al.: J. Biol. Chem., 270, 21619 (1995), Grand, R., et al.: J. Biochem., 313, 353 (1996), Ahn, H., et al.: Mol. Pharmacol., 51, 350 (1997);
?您的位置：
